TMS Co

TMS Co Liabilities

The The Liabilities of TMS Co (4891.T) as of Nov 4, 2026 is 95.00 M JPY. In the previous year, The Liabilities was 216.78 M JPY — a change of -56.18% (lower).

Liabilities

95.00 MJPY

YoY

-56.18%

Last updated:

In 2026, TMS Co's total liabilities amounted to 95.00 M JPY, a -56.18% difference from the 216.78 M JPY total liabilities in the previous year.

The TMS Co Liabilities history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Liabilities
Date
Liabilities
Jan 1, 2021
86.38 M JPY
Jan 1, 2022
286.78 M JPY
Jan 1, 2023
76.16 M JPY
Jan 1, 2024
97.69 M JPY
Jan 1, 2025
216.78 M JPY
Jan 1, 2026
95.00 M JPY
The TMS Co Liabilities history
YEARLiabilitiesYoY
95.00 MJPY-56.18%
216.78 MJPY+121.91%
97.69 MJPY+28.26%
76.16 MJPY-73.44%
286.78 MJPY+231.99%
86.38 MJPY—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

TMS Co Stock analysis

What does TMS Co do? TMS Co., Ltd. generates revenue through the research and development of pharmaceutical products and medical devices, focusing on drug candidates targeting soluble epoxide hydrolase (sEH). The company develops sEH inhibitors for inflammatory diseases, with its lead candidate TMS-007 undergoing clinical development for acute cerebral infarction. TMS-007 combines anti-inflammatory and thrombolytic effects by inhibiting sEH and acting on plasminogen. The follow-on product TMS-008 is in pre-clinical studies for various inflammatory diseases. The company collaborates with academia and research institutions for R&D results, leveraging external research to advance its pipeline. TMS Co., Ltd. targets the pharmaceutical market for inflammatory disease treatments, focusing on drug candidates with dual mechanisms of action. Its primary customers are pharmaceutical companies and research institutions seeking innovative therapeutic solutions. The company's pipeline includes TMS-007 for acute cerebral infarction and TMS-008 for broader inflammatory conditions, positioning itself in the biopharmaceutical segment. The firm's revenue model relies on advancing its pipeline through clinical and pre-clinical stages, with potential partnerships for further development and commercialization. TMS Co is one of the most popular companies on Eulerpool.

Liabilities Details

Assessing TMS Co's Liabilities

TMS Co's liabilities constitute the company's financial obligations and debts owed to external parties and stakeholders. They are categorized into current liabilities, due within a year, and long-term liabilities, which are due over a longer period. A detailed assessment of these liabilities is crucial for evaluating TMS Co's financial stability, operational efficiency, and long-term viability.

Year-to-Year Comparison

By comparing TMS Co's liabilities year-over-year, investors can identify trends, shifts, and anomalies in the company’s financial positioning. A decrease in total liabilities often signals financial strengthening, while an increase might indicate enhanced investments, acquisitions, or potential financial strain.

Impact on Investments

TMS Co's total liabilities play a significant role in determining the company's leverage and risk profile. Investors and analysts examine this aspect meticulously to ascertain the firm’s ability to meet its financial obligations, which influences investment attractiveness and credit ratings.

Interpreting Liability Fluctuations

Shifts in TMS Co’s liability structure indicate changes in its financial management and strategy. A reduction in liabilities reflects efficient financial management or debt payoffs, while an increase may suggest expansion, acquisition activities, or accruing operational expenses, each carrying distinct implications for investors.

Frequently Asked Questions about TMS Co stock

The Liabilities of TMS Co is 95.00 M JPY in 2026.

The Liabilities of TMS Co changed from 216.78 M JPY to 95.00 M JPY, representing a -56.18% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of The Liabilities TMS Co since 2006 – with annual values, charts, and detailed analysis.

The Liabilities's JPY is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track The Liabilities's TMS Co historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Balance Sheet — TMS Co

All Key Metrics — TMS Co